Ethyl-2,2-difluoro-2-(4-methylphenyl)acetate, 90.0%, 250mg

n-Dodecane, min. 95%, for synthesis, 1 l, glass packaging

1-(4-Nitrophenyl)piperidin-2-one, 95.0%, 1g

N-(tert-Butyl)-3-nitrobenzenesulfonamide, 95.0%, 1g

4-tert-Butoxycarbonylamino-benzoic acid, 97.0%, 1g

3-Amino-N-[3-(trifluoromethyl)phenyl]benzamide, 97%, 100mg

(S)-2-FLUORO-1-PHENYL-ETHYLAMINE HCL, 90.0%, 1g

METHYL 6-BROMO-1-METHYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 10g

5-Ethynylpyridin-3-amine, 97%, 100mg

4-(Methylamino)butanoic acid, 95.0%, 5g

7-(2-methoxyphenyl)-7-oxoheptanenitrile, 97.0%, 1g

2-(4-Hydroxyphenoxy)propanoic acid, 95.0%, 1g

(R)-2-((2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl)methyl)-6-(trifluoromethyl)phenol, 95%, 50mg